Surg Endosc2 Mar 2024
Transthoracic single-port-assisted laparoscopic gastrectomy (TSLG) demonstrates technical safety and feasibility in comparison to laparoscopic transhiatal approach (LTH) for Siewert type II adenocarcinoma of the esophagogastric junction. In a retrospective study, TSLG showed advantages, including increased harvested lymph nodes, reduced lower mediastinal lymph nodes, and longer…
Br J Surg1 Mar 2024
Recurrence-free survival is a valid surrogate endpoint for overall survival in surgically resectable advanced oesophageal squamous cell carcinoma (oscc) patients receiving neoadjuvant chemotherapy. A strong correlation (kendall's τ 0.797) was found between the two endpoints, particularly in patients with a more favorable response to neoadjuvant…
Ann Surg Oncol29 Feb 2024
Patients with 1 metastatic lymph node had a median overall survival of 49.8 months, while those with 2 metastatic lymph nodes had an overall survival of 33.3 months. Survival was not significantly different between patients with 1 metastatic lymph node in 1 lymph node metastasis…
Ann Surg Oncol29 Feb 2024
Proximal gastrectomy (PG) and total gastrectomy (TG) for upper-third advanced gastric cancer (AGC) and Siewert type II esophagogastric junction (EGJ) cancers yield similar overall survival rates (61.7% vs. 68.3%) and recurrence-free survival rates (86.7% vs. 83.3%). PG group had eight recurrences, but operation method was…
BMC Gastroenterol26 Feb 2024
Examining minimally invasive gastrectomy post-preoperative chemotherapy for advanced gastric cancer, this study included 150 patients, assessing safety and feasibility. The overall morbidity rate was 12%, with a higher incidence in total/proximal gastrectomy plus splenectomy cases. Robotic gastrectomy, especially in cases involving splenectomy, demonstrated significantly lower…
J Am Coll Surg25 Feb 2024
Researchers utilized an updated Markov model to compare life-years gained with elective laparoscopic paraesophageal hernia repair (ELHR) versus watchful waiting (WW) in patients aged 40-90 with symptoms, Cameron lesions, or comorbid conditions. ELHR was found to increase life expectancy over WW in most cases, particularly…
Hernia24 Feb 2024
Among 2170 patients undergoing laparoscopic hiatal hernia repair with follow-up, objective recurrence rates were 20.8% with suture repair, 20.6% with absorbable mesh, 13.7% with non-absorbable mesh, and 0% with partially absorbable mesh. Despite initial favor for non-absorbable mesh in the mid-term, all mesh types showed…
J Gastroenterol Hepatol24 Feb 2024
Results from a population-based study comparing early-onset and late-onset adenocarcinoma of esophagogastric junction demonstrated significantly better overall and cancer-specific survival in early-onset cases. Kaplan-Meier curves, multivariate Cox regression analyses, propensity score matching, and competing risk models all consistently showed a more favorable prognosis in early-onset…
Upper Gastrointestinal Tract24 Feb 2024
Survival benefit of surgery for second primary esophageal cancer following gastrointestinal cancer is significant. Surgery, year of diagnosis, regional lymph node surgery scope, tumor differentiation grade, SEER historic stage, and triple therapy are independent prognostic factors. In a cohort study of 582 patients, surgery significantly…
J Gastrointest Surg23 Feb 2024
Patients who underwent paraesophageal hernia repair without fundoplication did not report different rates of postoperative symptoms compared to those who did. The study found that fundoplication at the time of hernia repair may not reduce postoperative reflux, despite being a standard practice for sliding-type hiatal…